Eargo, the medical device company behind "virtually invisible" hearing aids, went public Friday in a bid to radically expand the market for hearing assistance.
"You don't have to be an old person," CEO Christian Gormsen told Cheddar. "You don't have to look like an old person. You don't have to go into a clinic."
The San Jose, California-based company began trading Friday on the Nasdaq under the ticker symbol "EAR" at the starting price of $18 per share. The stock price quickly doubled at the start of trading, hitting more than $38 by mid-afternoon.
"We want to be an industry innovator," he said. "Being a public company, first of all, helps us drive more awareness for hearing loss, which is critical, but it also gives us access to this amazing global investor base that we see as a great strength in terms of getting even better."
Gormsen added that 43 million Americans face hearing loss, while only a quarter do anything about it. By offering a less conspicuous hearing aid, the goal is to draw more of those people into the market.
"What's unique about Eargo is really that people don't want traditional hearing aids," he said. "We've developed a revolutionary medical technology device that actually sits invisibly behind your ear."
In addition, Eargo plans to grow its telephone and online marketing in an effort to reach consumers directly, rather than through a hearing clinic, where much of the hearing aid industry is based.
Gormsen also noted that this approach is especially important during the coronavirus pandemic.
"We've always been offering people to get hearing aids from the comfort, and now also from the safety, of their homes," he said.
The capital raised from the IPO will largely go into innovation, said Gormsen, given that the company is already well-funded.
"There's so much more we can do to make hearing aids even better in the future," he said.
Ben & Jerry’s co-founder Jerry Greenfield is leaving the ice cream brand after 47 years. He says the freedom the company used to have to speak up on social issues has been stifled
The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy.
Oracle soars as it cashes in on the AI boom, Plus: Starbucks shares continue to fall under its new CEO, and does anybody actually want a new iPhone Air?
Swedish buy now, pay later company Klarna is making its highly anticipated public debut on the New York Stock Exchange Wednesday, the latest in a run of high-profile initial public offerings this year. The offering priced at $40 Tuesday, above the forecasted range of $35 to $37 a share, valuing the company at more than $15 billion. The valuation easily makes Klarna one of the biggest IPOs so far in 2025, which has been one of the busier years for companies going public. Other popular IPOs so far this year include the design software company Figma and Circle Internet Group, which issues the USDC stablecoin..
Oracle co-founder Larry Ellison wrested the title of the world’s richest man from longtime holder Elon Musk early Wednesday as stock in his software giant rocketed more than a third in a stunning few minutes of trading. That is according to wealth tracker Bloomberg. A college dropout, the 81-year-old Ellison is now worth $393 billion, Bloomberg says, several billion more than Musk, who had been the world’s richest for four years. The switch in the ranking came after a blockbuster earnings report from Oracle. Forbes still has Musk as the richest, however, valuing his private businesses much higher.
